Using Bioactive Glasses in the Management of Burns
Saeid Kargozar
Masoud Mozafari
Sepideh Hamzehlou
Francesco Baino- 1Tissue Engineering Research Group (TERG), Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- 2Bioengineering Research Group, Nanotechnology and Advanced Materials Department, Materials and Energy Research Center (MERC), Tehran, Iran
- 3Cellular and Molecular Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
- 4Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
- 5Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
- 6Medical Genetics Network (MeGeNe), Universal Scientific Education and Research Network (USERN), Tehran, Iran
- 7Applied Science and Technology Department, Institute of Materials Physics and Engineering, Politecnico di Torino, Turin, Italy
The management of burn injuries is considered an unmet clinical need and, to date, no fully satisfactory solution exists to this problem. This mini-review aims to explore the potential of bioactive glasses (BGs) for burn care due to the therapeutic effects of their ionic dissolution products. BGs have been studied for more than 40 years and boast a long successful history in the substitution of damaged tissues, especially bone. Considering their exceptional versatility and attractive characteristics, these synthetic materials have also recently been proposed in the treatment of soft tissue-related disorders such as skin wounds. Specifically, improving fibroblast proliferation, inducing angiogenesis, and eliciting antibacterial activity (with the additional advantage of avoiding administration of antibiotics) are all considered as key added values carried by BGs in the treatment of burn injuries. However, some issues deserve careful consideration while proceeding with the research, including the selection of suitable BG compositions, appropriate forms of application (e.g., BG fibers, ointments or composite patches), as well as the procedures for reliable in vivo testing.
Introduction
Burn injury is a frequent cause of morbidity and mortality over the globe. Based on a report published in 2016, about 486,000 patients in the US received medical care for burn injuries from 2008 to 2016; however, 3,275 of those passed away because of the severity of the injuries (Association, 2016). Based on the injury degree, a burn leads to several complications including infection, hypothermia, scarring, as well as bone and joint problems (Sevitt, 1979). Among the difficulties as mentioned above, bacterial infections are the leading cause of death (42–65%) after extensive burn injuries (Sharma et al., 2006; Bloemsma et al., 2008; Keen et al., 2010; Krishnan et al., 2013). It has been shown that Gram-positive and Gram-negative multidrug-resistant (MDR) bacteria contribute to the burn infections in the first and late post-injury days, respectively (Lachiewicz et al., 2017). Therefore, the treatment of burns is of great importance, and the slow healing process and hypertrophic scarring are, in fact, unresolved challenges in burn research and management (Wang et al., 2018).
After any burn, various therapeutic agents (e.g., antibiotics and silver-containing ointments) can be used in order to prevent infection from developing as well as to kill the actual microbial cells (see Table 1) (Dai et al., 2010). It has been noted that there is no need for the administration of prophylactic oral antibiotics in the case of minor burns since they may create multi-resistant bacteria (Branski et al., 2009; Barajas-Nava et al., 2013). In this situation, antibacterial dressings can keep the bacterial colonization of wounds to a minimum (Hyland et al., 2015). Furthermore, it has been reported that the use of therapeutic substances that induce angiogenesis can lead to accelerating the repair and regeneration of burn wounds (Galeano et al., 2006; Oryan et al., 2018).
Table 1. A short list of topical antimicrobial agents used for burn therapy.
According to the criteria mentioned above, a feasible treatment approach that may fulfill all these requirements together and be actually and safely applied in the clinical practice still remain to be developed. In this regard, bioactive glasses (BGs) have been recently identified as promising substances for the management of soft tissue-related disorders. These synthetic biomaterials have been using for the treatment of acute and chronic wounds (Naseri et al., 2017; Kargozar et al., 2019). Releasing various therapeutic ions from BG structure into the biological environment is the main reason for their positive effects on wound healing (see Figure 1) and, more specifically, the great potential of BGs (as a topical therapy) could be exploited to treat burn injuries as many topical antimicrobial agents used for burns are cytotoxic to soft tissue cells (e.g., keratinocytes and fibroblasts), thus resulting in an unwanted delay in wound healing process (Lineaweaver et al., 1985; Barsoumian et al., 2013). The positive effects of BGs on the cells (e.g., keratinocytes) involved in better and faster healing of the burn wounds have been well-understood (Mârza et al., 2019), bringing new hopes in this important area of science.
Figure 1. The release of some metal ions from BGs into the surrounding environment has a positive effect on wound healing. Reproduced with some modifications from Naseri et al. (2017).
After providing a general picture of the suitability of BGs in contact with soft tissues – with emphasis on “general” wound healing applications (section Attractive Properties of BGs for Soft Tissue Repair) —, this mini-review highlights the potential of BGs in the context of burn treatment (section Evidence of BG Suitability for Treating Burns). Since there is a paucity of studies specifically dealing with BGs for the management of burns, an effort was done in section Evidence of BG Suitability for Treating Burns—whenever possible—to underline the specific relevance of other reports coming from the broader field of wound-healing applications.
Attractive Properties of BGs for Soft Tissue Repair
After four decades from their invention, BGs have gained an important status in the biomedical field (Baino et al., 2018, 2019). They are routinely used for treating various diseases form bone injuries to cancer metastases (Johari et al., 2016; Kargozar et al., 2016, 2017a, 2018d; Miola et al., 2019). The composition of the first BG developed by Prof. Larry Hench (melt-derived 45S5 Bioglass®) is based on a four-oxide system, 45SiO2-24.5Na2O−24.5CaO−6P2O5 (wt %), which has a high amount of Na2O and CaO as well as a relatively high CaO/P2O5 ratio that makes the surface of the material very reactive in physiological environment. This reactivity provides the BGs with the capability of bonding to both hard and soft living tissues (Baino et al., 2016). Although the primary types of BGs (silicate glasses) were designed and used for hard tissue engineering, especially bone healing, the use of them for soft tissue healing has also been reported. As an illustration, Yu et al. clarified that pre-treatment of fibroblasts by a silicate BG could be an effective approach for the activation of skin tissue engineering constructs for improved wound healing (Yu et al., 2015). The in vitro and in vivo experiments showed that BGs stimulate fibroblasts to overexpress some important growth factors and proteins (e.g., VEGF, bFGF, EGF, collagen type I, and fibronectin) which leads to (Association, 2016) an improvement in their migration ability, (Sevitt, 1979) an increment in the blood vessel formation, and (Krishnan et al., 2013) the differentiation of fibroblasts into myofibroblasts in the wound site. All the mentioned events, regulated via pretreatment with BG, resulted in an acceleration of wound healing process. Moreover, the efficacy of BGs for wound healing was shown at the molecular level as reported by Li et al. (2016b). They showed that 45S5 Bioglass® ion extracts could prevent the death of human umbilical vein endothelial cells (HUVECs) following hypoxia, possibly through connexin hemichannel modulation. The positive effects of BGs on gap junction communication as well as the overexpression of connexin43 (Cx43) and other molecules involved in wound healing, e.g., VEGF and FGF, were also reported by the authors.
Recent advances have shown that new compositions of BGs (e.g., borate and phosphate glasses) can be applied for soft tissue healing (e.g., wound healing) as well (Naseri et al., 2017). Compared to silicate glasses, borate- and phosphate-based BGs exhibit some in vitro and in vivo behaviors (e.g., high dissolution rate) which are in favor of soft tissue applications and quick replacement with new tissue (Rahaman et al., 2011). In this regard, Hu et al. evaluated the efficiency of copper-doped borate BG/poly (lactic-co-glycolic acid) dressing loaded with vitamin E (0-3.0 wt.%) for full-thickness wound healing (Hu et al., 2018). The in vitro results clarified that the ions released from the dressings encouraged the migration, tubule formation, and VEGF secretion in HUVECs and fibroblasts. Moreover, the data obtained from in vivo experiments revealed a substantial improvement in the epithelialization of wound closure and a significant increase in vessel sprouting and collagen remodeling. The authors stated that the use of this composite biomaterial as a wound dressing could actually be a promise for accelerating the healing and reconstruction of full-thickness skin defects.
After being incorporated into the structure of BGs, some specific ions may be subsequently released and elicit beneficial biological effects such as improved cell proliferation (Xynos et al., 2000), inhibition of bacterial growth (Zhang et al., 2010), and stimulation of angiogenesis (Kargozar et al., 2017b) (see Table 2 and Figure 2).
Table 2. Therapeutic ions useful for soft tissue healing applications.
Figure 2. The biological effects of BGs are related to the release of therapeutic ions from their structure into the surrounding environment. Reproduced with some modifications from Kargozar et al. (2018a).
For example, incorporation of silver ions (Ag+) into the glass structure imparts antimicrobial properties over various Gram-positive and Gram-negative bacterial strains (e.g., E. coli, P. aeruginosa, and S. aureus), without eliciting any toxic effect on human cells if silver is added under a threshold dosage (Miola and Verné, 2016). The release kinetics of therapeutic ions from BGs into the surrounding environment is determined by some factors such as the ionic radius of doping element, type of glass network, pH of the host environment, and temperature (Kargozar et al., 2018a).
As one of the most attractive types of BGs, mesoporous BGs (MBGs) are also considered as promising candidates for repair and regeneration of wound injuries (Wang et al., 2016; Kargozar and Mozafari, 2018). Experimental evidence showed that these materials could be used as suitable carriers for the controlled delivery of various therapeutic ions, drugs, and chemicals accelerating the healing process. The usability of MBGs have been previously well documented for antibacterial strategies (Gargiulo et al., 2013; Wu et al., 2013; Kargozar et al., 2018d) and angiogenesis-requiring applications (Dashnyam et al., 2017; Zhou et al., 2017; Romero-Sánchez et al., 2018). Also, Pourshahrestani et al. reported that gallium-containing MBGs could improve hemostasis via stimulating blood coagulation, platelet adhesion and thrombus generations (Pourshahrestani et al., 2016).
In the context of soft tissue engineering, Wang et al. developed a biocomposite made of copper-containing MBGs and nanofibrillated cellulose (NFC) as a suitable dressing material for chronic wound healing application (Wang et al., 2016). They reported that this composite showed high bioactivity in simulated body fluid (SBF) and could act as a matrix for the sustained release of Cu2+ ions which inhibited the bacterial growth and improved angiogenesis in order to promote wound healing. Other MBG-containing polymer biocomposites like chitosan (CS)/MBG porous films have also been developed as promising wound dressing materials (Jia et al., 2011).
Evidence of BG Suitability for Treating Burns
Generally, burns are categorized into four groups based on their depth and severity as 1st, 2nd, 3rd, and 4th degree. The extent of the injury is limited to only the epidermis in the first-degree burns, while it involves more layers of skin in the second-degree burns including the superficial (papillary) dermis and also the deep (reticular) dermis layer. The epidermis is lost, and damage to the subcutaneous tissue occurs in the case of third-degree burns; in addition to that, damage to the muscle, tendon, and ligament tissue are observed in the fourth-degree burns (Dai et al., 2010). It has been well documented that burns >10% of total body surface area (%TBSA) in children or 15% in adults are potentially life-threatening injuries as a result of the risk of hypovolemic shock (Malic et al., 2007).
A few criteria are typically counted for any medication used to treat or reduce the symptoms of burn injuries, i.e., attenuating inflammation, reducing infection, removing excessive exudates, and improving angiogenesis, thereby accelerating the healing process (Rowan et al., 2015). The promise of BGs in meeting these requirements is illustrated in Table 3. As previously mentioned, antimicrobial dressings are recommended for the management of minor burns (Hyland et al., 2015). However, it has been stated that there is no need for wound coverage if the skin is intact and not blistered. In this condition, the use of a simple moisturizer (e.g., silver sulfadiazine cream) has been recommended (Australian NZB Association, 2002). On the other hand, excessive or prolonged inflammation can result in impaired wound healing (Sommer et al., 2013). It is possible to prepare some compositions of BGs with the ability to reduce inflammation (Varmette et al., 2009) and bacterial infection (Coraça-Huber et al., 2014). As mentioned above, chronic inflammation is one of the main complications in patients with large burns which may impair wound healing (Ueno et al., 2005). The efficacy of 45S5 Bioglass® on human macrophages and monocytes has been previously studied in vitro, showing its potential in terms of attenuating inflammatory responses (Day and Boccaccini, 2005). Moreover, there is a hope to improve the anti-inflammatory effects of BGs through doping with some specific ions (e.g., Zn2+ and Li+).
Table 3. Potential capability of BGs to meet the criteria required for burn management.
From the antibacterial point of view, it has been shown that BGs can decrease the risk of infections caused by both Gram-positive and Gram-negative strains (Liu et al., 2016a,b; Ottomeyer et al., 2016). This decrease can be achieved through two mechanisms (usually combined) regulated by the dissolution of BGs, including (i) the local increase of pH values in the injured site (due to the delivery of alkaline cations such as Ca2+ and Na+) and (ii) the release of antibacterial ions (e.g., silver, copper, zinc, cerium, and gallium) (Ratha et al., 2018; Bauer et al., 2019; Wajda et al., 2019). However, it has been documented that the effect of pH depends on the species of bacteria involved. For example, Wiegand et al. showed that S. aureus exhibits an increased sensitivity against silver nitrate with rising pH while P. aeruginosa exhibits a decreased sensitivity (Wiegand et al., 2015). In order to illustrate the potential suitability of BGs in the specific context of burn injuries, Gholipourmalekabadi et al. compared the antibacterial activity of silver- and fluoride-containing BGs vs. commonly-used antibiotics on multidrug-resistant bacterial strains (K. pneumonia, S. aureus, E. coli, and P. aeruginosa) isolated from patients with burns (Gholipourmalekabadi et al., 2016). Their results revealed that, although fluoride-doped BGs did not show any antibacterial activity against the tested bacteria, BGs doped with 1 and 2% of silver significantly inhibited the bacterial growth in vitro in all cases (inhibition zone up to 11 ± 1 mm). On the basis of this early experimental evidence, they concluded that silver-doped BGs could play an important role in the prevention of burn-associated infections, reduction of pain, and removal of excessive exudates. The capability of removing exudates is of great importance since they can fail the dressing to stick to the injured tissues and subsequently disrupt the wound healing process.
At present, other specific studies dealing with the efficacy of BGs against the typical bacteria of infected burns are not available in the literature; however, the potential suitability of BGs for the management of burns can be supported by other results from “general” wound healing applications.
The formulation of BGs for use in wound injuries (and hence in burns) is of paramount importance. In this regard, Lin et al. prepared BG ointments by mixing 58S sol-gel BG micro-particles (SGBG-58S), 58S nano-BG (NBG-58S) and melt-derived 45S5 BG (45S5) powder with Vaseline (V) at 18 wt.% (Lin et al., 2012). They used this formulation for the treatment of full-thickness skin wounds in both normal and diabetic rats, whose injuries did not heal under conventional treatment. The obtained data revealed that all the compositions could accelerate the wound healing as a result of improving the proliferation of fibroblasts and growth of granulation tissue as well as the induction of angiogenesis. In addition to the susceptibility to infections, destruction of the vascular supply to the burned skin is one of the main barriers to the repair of injured tissue (Guo et al., 2011). Hence, improving angiogenesis regulated by BGs can be considered as a promising point regarding burn healing. The release of specific metal ions (e.g., copper and cobalt) from BGs into the surrounding environment can promote angiogenesis via hypoxia-mimicking pathways (Quinlan et al., 2015; Lin et al., 2016b; Balasubramanian et al., 2017; Kargozar et al., 2018b). Angiogenesis is vital to allow and/or accelerate the healing of burn wounds. On this matter, Li et al. developed BG/chitosan/silk fibroin composite scaffolds for the regeneration of deep burn wounds (Li et al., 2016a). The authors used these components with three specific and distinct aims: BG was included for inducing angiogenesis, chitosan for promoting the adsorption and enrichment of growth factors, and silk fibroin for providing a three-dimensional (3D) porous structure and mechanical support. Their results showed that adding BGs to the composites was the key to promote the formation and maturation of new blood vessels, which can significantly accelerate the wound healing process (see Figure 3).
Figure 3. Direct observation of the burn wounds created in rats and treated with silk fibroin (SF)/chitosan (CHI), BG/SF, BG/CHI and BG/CHI/SF scaffolds after 3, 7, 14, 21, and 28 days. Reproduced with permission from Li et al. (2016a).
Looking at the future and considering the peculiar properties that a biomaterial in contact with burns should exhibit, MBGs doped with therapeutic ions (see Table 2) could be regarded as ideal candidates being capable to act as multifunctional systems eliciting a local antibacterial effect and promoting angiogenesis, which are both crucial features required for the successful management of burns; furthermore, their highly-porous structure could be useful in adsorbing burn exudates.
As a further promising point, the sustained release of bioactive molecules that can be potentially effective in burn healing [e.g., epidermal growth factor (EGF)] via MBGs has been previously carried out; however, those studies were addressed to another application, i.e., the acceleration of bone regeneration (Wang et al., 2017).
Implications and Conclusions
The impact of using BGs for the management of burns would be highly significant from multiple viewpoints including scientific, clinical, commercial, and socio-economical aspects. Specifically, MBGs show great promise due to their exceptional processing versatility and capability of acting as multifunctional platforms for the local release of therapeutic ions and biomolecules(Wu and Chang, 2014), which could perform a synergistic action (e.g., anti-inflammatory, antibacterial and angiogenic effects) addressed to promote the healing of burn injuries (see Figure 4). From a clinical perspective, the use of therapeutic inorganic agents (i.e., ionic dissolution products) released from BGs or MBGs to treat burn-related infections could ideally allow overcoming the problem of resistant bacterial strains, which has been associated to the abuse of antibiotics in the last decades and is one of the grand challenges of the 21st century (Ventola, 2015). In fact, bacteria cannot be resistant to the effects of some inorganic cations, such as Ag+, that typically cause the disruption of the membrane after linking to the membrane proteins (Silvestry-Rodriguez et al., 2007).
Figure 4. Schematic representation of possibilities of BGs for the treatment of burns. With some modifications from Homayoon (2015).
From a commercial viewpoint, BG-based medical products intended for the treatment of burn injuries would be unique and highly novel. At present, no BG-based commercial medication is available for this specific purpose. There is also a paucity of BG-based commercial products for “general” wound healing. Cotton-candy 13-93B3 borate BG (53B2O3-20CaO-12K2O-6Na2O-5MgO-4P2O5 wt.%, trade-named as “Dermafuse”) has been recently commercialized by Mo-Sci Corporation (USA) to accelerate wound healing in veterinary medicine and has also shown great promise for use in diabetic human patients suffering from chronic wounds (Wray, 2011). This material has a nanofibrous structure, so that blood platelets are trapped on the BG fibers that offer mechanical support and stability for tissue migration and the wound healing process. The fibers dissolve over time and form hydroxyapatite microspheres, to which blood vessels can attach. The antibacterial and proangiogenic properties of 13-93B3 BG formulation could justify the evaluation of this material for treating burn injuries, too. An evolution of this material was recently investigated by Lin et al. who successfully incorporates Cu2+ ions into 13-93B3 BGs microfibers and prepared wound dressings with an enhanced capability to stimulate angiogenesis, thereby significantly accelerating the healing of full-thickness skin defects in a rodent model (Lin et al., 2014) (Figure 5).
Figure 5. Cotton-like fibrous scaffolds produced and implanted subcutaneously in rats including (A) 45S5 glass, (B) 13–93B3 glass, and (C) Cu-doped 13–93B3 glass; (D) higher magnification of the 13–93B3 glass microfibers with glass beads of variable size; (E) the mat of copper-containing 13–93B3 glass microfibers for implantation in rats (E). Images reproduced from Lin et al. (2014) with permission.
Appropriate in vitro and in vivo burn models should also be developed to test the suitability of BGs for this specific application; an overview of common testing methods is reported elsewhere (Qu and Nourbakhsh, 2017). It is stated that the method used to induce burns in experimental animals is, in fact, one of the most critical factors of clinical and ethical relevance; therefore, efforts should be made to reduce in vivo experiments to a minimum. In this regard, direct contact with a heated metal (usually created on the back of the animals) (Campelo et al., 2011), electricity (usually performed on large animals) (Zelt et al., 1988), and heated water (more widespread use) (Dahiya, 2009) are the commonly-used approaches to generate burn surfaces in experimental animal models (mouse, rat, pig, and monkey) (Abdullahi et al., 2014).
The selection of the most suitable form of application of BGs for burn care is another aspect deserving careful consideration. Surgeons typically claim an off-of-the-shelf and easy-to-use product that can fit the burn extension and homogeneously cover its surface. Three potential forms of application might be considered, i.e., fibrous BG constructs (such as the above-mentioned “Dermafuse”), BG-containing ointments that could be easily spread topically and pliable composites (for example BG micro- or nano-inclusions embedded in a soft polymeric sheet or gel) (Kargozar et al., 2018e). The feasibility of all these potential products has already been reported in the biomaterials literature or industry, although in other contexts than burn care: thus, no particular problems are expected to arise from a processing viewpoint due to the great “technological” versatility of BGs.
Last but not least, given the absence of biomolecules (drugs) incorporated in this new product for the treatment of burn injuries, the regulatory procedure required for clinical approval and use is expected not to be a tremendously draining and resource-consuming path, so that a large number of patients can benefit soon from these achievements.
Data Availability
All datasets generated for this study are included in the manuscript and the supplementary files.
Author Contributions
SK: writing the first draft; MM: revision; SH: preparation of Figures and Tables; FB: final revision.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Abdullahi, A., Amini-Nik, S., and Jeschke, M. (2014). Animal models in burn research. Cell. Mol. Life Sci. 71, 3241–3255. doi: 10.1007/s00018-014-1612-5
Abou Neel, E., Ahmed, I., Pratten, J., Nazhat, S., and Knowles, J. (2005). Characterisation of antibacterial copper releasing degradable phosphate glass fibres. Biomaterials 26, 2247–2254. doi: 10.1016/j.biomaterials.2004.07.024
Association, A. B. (2016). National Burn Repository 2015 Report Version 11.0. 2015. Chicago, IL: American Burn Association.
Australian and NZB Association. (2002). Emergency Management of Severe Burns Manual. Sydney: The Education Committee of the Australian and New Zealand Burns Association, Ltd.
Baino, F., Fiume, E., Barberi, J., Kargozar, S., Marchi, J., Massera, J., et al. (2019). Processing methods for making porous bioactive glass-based scaffolds—A state-of-the-art review. Int. J. Appl. Ceramic Technol. 1–35. doi: 10.1111/ijac.13195
Baino, F., Hamzehlou, S., and Kargozar, S. (2018). Bioactive glasses: where are we and where are we going? J. Funct. Biomater. 9:25. doi: 10.3390/jfb9010025
Baino, F., Novajra, G., Miguez-Pacheco, V., Boccaccini, A. R., and Vitale-Brovarone, C. (2016). Bioactive glasses: special applications outside the skeletal system. J. Non-Crystalline Solids 432, 15–30. doi: 10.1016/j.jnoncrysol.2015.02.015
Balasubramanian, P., Hupa, L., Jokic, B., Detsch, R., Grünewald, A., and Boccaccini, A. R. (2017). Angiogenic potential of boron-containing bioactive glasses: in vitro study. J. Mater. Sci. 52, 8785–8792. doi: 10.1007/s10853-016-0563-7
Barajas-Nava, L. A., López-Alcalde, J., Roqué i Figuls, M., Solà, I., and Bonfill Cosp, X. (2013). Antibiotic prophylaxis for preventing burn wound infection. Cochr Database Syst Rev. CD008738. doi: 10.1002/14651858.CD008738.pub2
Barnea, Y., Weiss, J., and Gur, E. (2010). A review of the applications of the hydrofiber dressing with silver (Aquacel Ag®) in wound care. Therapeut. Clin. Risk Manag. 6:21. doi: 10.2147/TCRM.S3462
Barsoumian, A., Sanchez, C. J., Mende, K., Tully, C. C., Beckius, M. L., Akers, K. S., et al. (2013). In vitro toxicity and activity of Dakin's solution, mafenide acetate, and amphotericin B on filamentous fungi and human cells. J. Orthopaedic Trauma 27, 428–436. doi: 10.1097/BOT.0b013e3182830bf9
Bauer, J., Silva e Silva, A., Carvalho, E. M., Ferreira, P. V. C., Carvalho, C. N., Manso, A. P., et al. (2019). Dentin pretreatment with 45S5 and niobophosphate bioactive glass: Effects on pH, antibacterial, mechanical properties of the interface and microtensile bond strength. J. Mech. Behav. Biomed. Mater. 90, 374–380. doi: 10.1016/j.jmbbm.2018.10.029
Bloemsma, G., Dokter, J., Boxma, H., and Oen, I. (2008). Mortality and causes of death in a burn centre. Burns 34, 1103–1107. doi: 10.1016/j.burns.2008.02.010
Branski, L. K., Al-Mousawi, A., Rivero, H., Jeschke, M. G., Sanford, A. P., and Herndon, D. N. (2009). Emerging infections in burns. Surg. Infect. 10, 389–397. doi: 10.1089/sur.2009.024
Brown, M., and Wood, S. M. (1972). Relation between cation and lipid content of cell walls of Pseudomonas aeruginosa, Proteus vulgaris and Klebsiella aerogenes and their sensitivity to polymyxin B and other antibacterial agents. J. Pharm. Pharmacol. 24, 215–218. doi: 10.1111/j.2042-7158.1972.tb08967.x
Campelo, A. P. B. S., Campelo, M. W. S., Britto, G. A. d. C., Ayala, A. P., Guimarãe, S. B., Vasconcelos, P. R. L. d., et al. (2011). Vasconcelos. An optimized animal model for partial and total skin thickness burns studies. Acta Cirurgica Brasileira 26, 38–42. doi: 10.1590/S0102-86502011000700008
Chalekson, C. P., Neumeister, M. W., and Jaynes, J. (2002). Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel). Plastic Reconstruct. Surg. 109, 1338–1343. doi: 10.1097/00006534-200204010-00020
Chigurupati, S., Mughal, M. R., Okun, E., Das, S., Kumar, A., McCaffery, M., et al. (2013). Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing. Biomaterials 34, 2194–2201. doi: 10.1016/j.biomaterials.2012.11.061
Coraça-Huber, D. C., Fille, M., Hausdorfer, J., Putzer, D., and Nogler, M (2014). Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. J. Orthop. Res. 32, 175–177. doi: 10.1002/jor.22463
Dai, T., Tegos, G. P., Burkatovskaya, M., Castano, A. P., Hamblin, M. R., et al. (2009). Chitosan acetate bandage as a topical antimicrobial dressing for infected burns. Antimicrobial. Agents Chemother. 53, 393–400. doi: 10.1128/AAC.00760-08
Dai, T. Y., Huang, Y. K., Sharma, S. T., Hashmi, J. B., Kurup, D., and Hamblin, M. R. (2010). Topical antimicrobials for burn wound infections. Recent Patents Anti-Infect Drug Discov. 5, 124–151. doi: 10.2174/157489110791233522
Dashnyam, K. G., Jin, Z. J., Kim, H., Perez, R.J, Jang, H., and Kim, H. W. (2017). Promoting angiogenesis with mesoporous microcarriers through a synergistic action of delivered silicon ion and VEG. Biomaterials F. 116, 145–157. doi: 10.1016/j.biomaterials.2016.11.053
Davan, R., Prasad, R., Jakka, V. S., Aparna, R., Phani, A., Jacob, B., et al. (2012). Cerium oxide nanoparticles promotes wound healing activity in in-vivo animal model. J. Bionanosci. 6, 78–83. doi: 10.1166/jbns.2012.1074
Day, R. M., and Boccaccini, A. R. (2005). Effect of particulate bioactive glasses on human macrophages and monocytes in vitro. J. Biomed. Mater. Res. Part A. 73, 73–79. doi: 10.1002/jbm.a.30262
Demirci, S., Dogan, A., Aydin, S., Dülger, E. Ç., and Sahin, F. (2016). Boron promotes streptozotocin-induced diabetic wound healing: roles in cell proliferation and migration, growth factor expression, and inflammation. Mol. Cel. Biochem. 417, 119–133. doi: 10.1007/s11010-016-2719-9
Deters, A., Schnetz, E., Schmidt, M., and Hensel, A. (2003). Effects of zinc histidine and zinc sulfate on natural human keratinocytes. Compl. Med. Res. 10, 19–25. doi: 10.1159/000069903
Epand, R. M., Epand, R. F., and andSavage, P. B. (2008). Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents. Drug News Perspect. 21, 307–311. doi: 10.1358/dnp.2008.21.6.1246829
Fong, J., and Wood, F. (2006). Nanocrystalline silver dressings in wound management: a review. Int. J. Nanomed. 1, 441. doi: 10.2147/nano.2006.1.4.441
Fox, C. L. (1968). Silver sulfadiazine—a new topical therapy for pseudomonas in burns: therapy of pseudomonas infection in burns. Arch. Surg. 96, 184–188. doi: 10.1001/archsurg.1968.01330200022004
Galeano, M., Altavilla, D., Bitto, A., Minutoli, L., Calò, M., Cascio, P., et al. (2006). Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit. Care Med. 34, 1139–1146. doi: 10.1097/01.CCM.0000206468.18653.EC
Ganz, T. (2009). Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710X. doi: 10.1038/nri1180
Gargiulo, N., Cusano, A. M., Causa, F., Caputo, D., and Netti, P. A. (2013). Silver-containing mesoporous bioactive glass with improved antibacterial properties. J. Mater. Sci. Mater. Med. 24, 2129–2135. doi: 10.1007/s10856-013-4968-4
Gholipourmalekabadi, M., Sameni, M., Hashemi, A., Zamani, F., Rostami, A., and Mozafari, M. (2016). Silver-and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: activity against multidrug-resistant bacterial strains isolated from patients with burns. Burns 42, 131–140. doi: 10.1016/j.burns.2015.09.010
Guo, R., Xu, S., Ma, L., Huang, A., and Gao, C. (2011). The healing of full-thickness burns treated by using plasmid DNA encoding VEGF-165 activated collagen–chitosan dermal equivalents. Biomaterials 32, 1019–1031. doi: 10.1016/j.biomaterials.2010.08.087
Haynes, B. W. (1971). Mafenide acetate in burn treatment. N. Engl. J. Med. 284, 1324–1324. doi: 10.1056/NEJM197106102842310
Hu, H., Tang, Y., Pang, L., Lin, C., Huang, W., Wang, D., et al. (2018). Angiogenesis and full-thickness wound healing efficiency of a copper-doped borate bioactive Glass/Poly(lactic-co-glycolic acid) Dressing Loaded with Vitamin E in vivo and in vitro. ACS Appl. Mater. Interfaces 10, 22939–22950. doi: 10.1021/acsami.8b04903
Hyland, E. J., Connolly, S. M., Fox, J. A., and Harvey, J. G. (2015). Minor burn management: potions and lotions. Aust. Prescr. 38, 124–127. doi: 10.18773/austprescr.2015.041
Jacobsen, F., Mittler, D., Hirsch, T., Gerhards, A., Lehnhardt, M., Voss, B., et al. (2005). Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Therap. 12, 1494. doi: 10.1038/sj.gt.3302568
Jia, T. B., Chen, J. Y., Feng, X., and Chang, J. (2011). Fabrication and characterization of chitosan/mesoporous bioactive glasses porous films. J. Clin. Rehabil. Tissue Eng. Res. 15, 7877–7880. doi: 10.3969/j.issn.1673-8225.2011.42.021
Johari, B., Kadivar, M., Lak, S., Gholipourmalekabadi, M., Urbanska, A. M., Mozafari, M, et al. (2016). Osteoblast-seeded bioglass/gelatin nanocomposite: a promising bone substitute in critical-size calvarial defect repair in rat. Int. J. Arti. Org. 39, 524–533. doi: 10.5301/ijao.5000533
Johnson, B. A., Anker, H., and Meleney, F. L. (1945). Bacitracin: a new antibiotic produced by a member of the B. Subt. Group. Sci. 102, 376–377. doi: 10.1126/science.102.2650.376
Jørgensen, B., Price, P., Andersen, K. E., Gottrup, F., Bech Thomsen, N, Scanlon, E., et al. (2005). The silver-releasing foam dressing, contreet foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial. Int. Wound J. 2, 64–73. doi: 10.1111/j.1742-4801.2005.00084.x
Kargozar, S., Baino, F., Hamzehlou, S., Hill, R. G., and Mozafari, M. (2018a). Bioactive glasses entering the mainstream. Drug Discovery Today 23, 1700–1704. doi: 10.1016/j.drudis.2018.05.027
Kargozar, S., Baino, F., Hamzehlou, S., Hill, R. G., and Mozafari, M. (2018b). Bioactive glasses: sprouting angiogenesis in tissue engineering. Trends Biotechnol. 36, 430–444. doi: 10.1016/j.tibtech.2017.12.003
Kargozar, S., Baino, F., Hoseini, S. J., Hamzehlou, S., Darroudi, M., Verdi, J., et al. (2018c). Biomedical applications of nanoceria: new roles for an old player. Nanomedicine 13, 3051–3069. doi: 10.2217/nnm-2018-0189
Kargozar, S., Hamzehlou, S., and Baino, F. (2017a). Potential of bioactive glasses for cardiac and pulmonary tissue engineering. Materials 10:1429. doi: 10.3390/ma10121429
Kargozar, S., Hamzehlou, S., and Baino, F. (2019). Can bioactive glasses be useful to accelerate the healing of epithelial tissues? Mater. Sci. Eng. C 97, 1009–1020. doi: 10.1016/j.msec.2019.01.028
Kargozar, S., Lotfibakhshaiesh, N., Ai, J., Mozafari, M., Brouki Milan, P., Hamzehlou, S., et al. (2017b). Joghataei. Strontium- and cobalt-substituted bioactive glasses seeded with human umbilical cord perivascular cells to promote bone regeneration via enhanced osteogenic and angiogenic activities. Acta Biomaterialia 58(Suppl. C), 502–514. doi: 10.1016/j.actbio.2017.06.021
Kargozar, S., Lotfibakhshaiesh, N., Ai, J., Samadikuchaksaraie, A., Hill, R. G., Shah, P. A., et al. (2016). Synthesis, physico-chemical and biological characterization of strontium and cobalt substituted bioactive glasses for bone tissue engineering. J. Non-Crystalline Solids 449, 133–140. doi: 10.1016/j.jnoncrysol.2016.07.025
Kargozar, S., Montazerian, M., Hamzehlou, S. H., Kim, W., and Baino, F. (2018d). Mesoporous bioactive glasses: promising platforms for antibacterial strategies. Acta Biomaterialia 81, 1–19. doi: 10.1016/j.actbio.2018.09.052
Kargozar, S., and Mozafari, M. (2018). Nanotechnology and Nanomedicine: Start small, think big. Materials Today. Proc. 5(7, Part 3), 15492–15500. doi: 10.1016/j.matpr.2018.04.155
Kargozar, S., Mozafari, M., Hill, R. G., Brouki Milan, P., Taghi Joghataei, M., Hamzehlou, S., et al. (2018e). Synergistic combination of bioactive glasses and polymers for enhanced bone tissue regeneration. Mater. Today. Proc. 5, 15532–15539. doi: 10.1016/j.matpr.2018.04.160
Kawai, K., Larson, B. J., Ishise, H., Carre, A. L., Nishimoto, S., Longaker, M., et al. (2011). Calcium-based nanoparticles accelerate skin wound healing. PLoS ONE 6:e27106. doi: 10.1371/journal.pone.0027106
Kaygusuz, H., Torlak, E., Akin-Evingür, G., Özen, I., von Klitzing, R., and Erim, F. B. (2017c). Antimicrobial cerium ion-chitosan crosslinked alginate biopolymer films: a novel and potential wound dressing. Int. J. Biol. Macromol. 105, 1161–1165. doi: 10.1016/j.ijbiomac.2017.07.144
Keen, E. F., Robinson, B. J., Hospenthal, D. R., Aldous, W. K., Wolf, S. E., Chung, K. K, et al. (2010). Incidence and bacteriology of burn infections at a military burn center. Burns 36, 461–468. doi: 10.1016/j.burns.2009.10.012
Kornblatt, A. P., Nicoletti, V. G., and Travaglia, A. (2016). The neglected role of copper ions in wound healing. J. Inorgan. Biochem. 161, 1–8. doi: 10.1016/j.jinorgbio.2016.02.012
Krishnan, P., Frew, Q., Green, A., Martin, R., and Dziewulski, P. (2013). Cause of death and correlation with autopsy findings in burns patients. Burns 39, 583–588. doi: 10.1016/j.burns.2012.09.017
Lachiewicz, A. M., Hauck, C. G., Weber, D. J., Cairns, B. A., and van Duin, D. (2017), Bacterial infections after burn injuries: impact of multidrug resistance. Clin. Infect. Dis. 65, 2130–2136. doi: 10.1093/cid/cix682
Lansdown, A. B. (2002). Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regener. 10, 271–285. doi: 10.1046/j.1524-475X.2002.10502.x
Lansdown, A. B., Mirastschijski, U., Stubbs, N., Scanlon, E., and Ågren, M. S. (2007). Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regener. 15, 2–16. doi: 10.1111/j.1524-475X.2006.00179.x
Li, D., Jiao, G., Zhang, W., Chen, X., Ning, R., and Du, C. (2016a). Hybrid scaffolding strategy for dermal tissue reconstruction: a bioactive glass/chitosan/silk fibroin composite. RSC Adv. 6, 19887–19896. doi: 10.1039/C5RA26871K
Li, H., He, J., Yu, H., Green, C. R., and Chang, J. (2016b). Bioglass promotes wound healing by affecting gap junction connexin 43 mediated endothelial cell behavior. Biomaterials 84, 64–75. doi: 10.1016/j.biomaterials.2016.01.033
Lin, C., Mao, C., Zhang, J., Li, Y., and Chen, X. (2012). Healing effect of bioactive glass ointment on full-thickness skin wounds. Biomed. Mater. 7:045017. doi: 10.1088/1748-6041/7/4/045017
Lin, Y., Brown, R. F., Jung, S. B., and Day, D. E. (2014). Angiogenic effects of borate glass microfibers in a rodent model. J. Biomed. Mater. Res. Part A. 102, 4491–4499. doi: 10.1002/jbm.a.35120
Lin, Y., Xiao, W., Bal, B. S., and Rahaman, M. N. (2016b). Effect of copper-doped silicate 13–93 bioactive glass scaffolds on the response of MC3T3-E1 cells in vitro and on bone regeneration and angiogenesis in rat calvarial defects in vivo. Mater. Sci. Eng. C, 67, 440–452. doi: 10.1016/j.msec.2016.05.073
Lin, Y. H., Hsu, W. S., Chung, W. Y., Ko, T. H., and Lin, J. H. (2016a). Silver-based wound dressings reduce bacterial burden and promote wound healing. Int. Wound J. 13, 505–511. doi: 10.1111/iwj.12467
Lineaweaver, W., McMorris, S., Soucy, D., and Howard, R. (1985). Cellular and bacterial toxicities of topical antimicrobials. Plastic Reconstruct Surg. 75, 394–396. doi: 10.1097/00006534-198503000-00016
Liu, J., Rawlinson, S. C., Hill, R. G., and Fortune, F. (2016a). Fluoride incorporation in high phosphate containing bioactive glasses and in vitro osteogenic, angiogenic and antibacterial effects. Dental Mater. 32, e221–e237. doi: 10.1016/j.dental.2015.12.013
Liu, J., Rawlinson, S. C., Hill, R. G., and Fortune, F. (2016b). Strontium-substituted bioactive glasses in vitro osteogenic and antibacterial effects. Dental Mater. 32, 412–422.
Mârza, S. M., Magyari, K., Bogdan, S., Moldovan, M., Peştean, C., et al. (2019). Skin wound regeneration with bioactive glass-gold nanoparticles ointment. Biomed. Mat. 14:025011. doi: 10.1088/1748-605X/aafd7d
Malic, C. C., Karoo, R. O. S, Austin, O., and Phipps, A. (2007). Resuscitation burn card—A useful tool for burn injury assessment. Burns 33, 195–199. doi: 10.1016/j.burns.2006.07.019
Meaume, S., Vallet, D., Nguyen Morere, M., and Teot, L. (2005). Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J. Wound Care 14, 411–419. doi: 10.12968/jowc.2005.14.9.26835
Miola, M., Pakzad, Y., Banijamali, S., Kargozar, S., Vitale-Brovarone, C., Yazdanpanah, A., et al. (2019). Glass-ceramics for cancer treatment: So close, or yet so far? Acta Biomaterialia 83, 55–70. doi: 10.1016/j.actbio.2018.11.013
Miola, M., and Verné, E. C. (2016). Vitale-Brovarone and F. baino. antibacterial bioglass-derived scaffolds. innovative synthesis approach and characterization. Int. J. Appl. Glass Sci. 7, 238–247. doi: 10.1111/ijag.12209
Monafo, W., Tandon, S., Ayvazian, V., Tuchschmidt, J., Skinner, A., and Deitz, F. (1976). Cerium nitrate: a new topical antiseptic for extensive burns. Surgery 80, 465–473.
Moyer, C. A., Brentano, L., Gravens, D. L., Margraf, HW., and Monafo, WW. (1965). Treatment of large human burns with 0.5% silver nitrate solution. Arch. Surg. 90, 812–867. doi: 10.1001/archsurg.1965.01320120014002
Munster, A. M. (1984). Treatment of invasive Enterobacter cloacae burn wound sepsis with topical nitrofurazone. J. Trauma 24, 524–525. doi: 10.1097/00005373-198406000-00010
Naseri, S., Lepry, W. C., and Nazhat, S. N. (2017). Bioactive glasses in wound healing: hope or hype? J. Mater. Chem. B. 5, 6167–74. doi: 10.1039/C7TB01221G
Orosz, C. G., Wakely, E., Bergese, S. D., VanBuskirk, A., and Erim, F. B. (1996). Prevention of murine cardiac allograft rejection with gallium nitrate: comparison with Anti-CD4 Monoclonal Antibody1. Transplantation 61, 783–791. doi: 10.1097/00007890-199603150-00019
Oryan, A., Alemzadeh, E., and Eskandari, M. H. (2018). Kefir accelerates burn wound healing through inducing fibroblast cell migration in vitro and modulating the expression of IL-1ss, TGF-ss1, and bFGF genes in vivo. Probiot. Antimicrobial Proteins, 1–13. doi: 10.1007/s12602-018-9435-6
Ottomeyer, M., Mohammadkah, A., Day, D., and Westenberg, D. J. (2016). Broad-spectrum antibacterial characteristics of four novel borate-based bioactive glasses. Adv. Microbiol. 6, 776–787. doi: 10.4236/aim.2016.610076
Palmieri, T. L., and Greenhalgh, D. G. (2002). Topical treatment of pediatric patients with burns. Am. J. Clin. Dermatol. 3, 529–534. doi: 10.2165/00128071-200203080-00003
Pourshahrestani, S., Zeimaran, E., Kadri, N. A., Gargiulo, N., Samuel, S., Naveen, S. V., et al. (2016). Gallium-containing mesoporous bioactive glass with potent hemostatic activity and antibacterial efficacy. J. Mater. Chem. B. 4, 71–86. doi: 10.1039/C5TB02062J
Quinlan, E., Partap, S., Azevedo, M. M., Jell, G., Stevens, M., O'Brien, F. J., et al. (2015). Hypoxia-mimicking bioactive glass/collagen glycosaminoglycan composite scaffolds to enhance angiogenesis and bone repair. Biomaterials 52, 358–366. doi: 10.1016/j.biomaterials.2015.02.006
Rahaman, M. N., Day, D. E., Bal, B. S., Fu, Q., Jung, S. B., Bonewald, L. F, et al. (2011). Bioactive glass in tissue engineering. Acta biomaterialia 7, 2355–2373. doi: 10.1016/j.actbio.2011.03.016
Ramenzoni, L. L., Weber, F. E., Attin, T., and Schmidlin, P. R. (2017). Cerium chloride application promotes wound healing and cell proliferation in human foreskin fibroblasts. Materials 10, 573. doi: 10.3390/ma10060573
Ratha, I., Adarsh, T., Anand, A., Sinha, P. K., Diwan, P., Annapurna, K., et al. (2018). In vitro bioactivity and antibacterial properties of bismuth oxide modified bioactive glasses. J. Mater. Res. 33, 178–190. doi: 10.1557/jmr.2017.442
Ren, H., Han, C., Zhang, R., Xu, Z., Meng, Z., Weng, H., et al. (2006). The antibacterial effect of cecropin B on Pseudomonas aeruginosa infection of wounds in mice. Zhonghua shao shang 22, 445–447.
Ribeiro, M. P., Espiga, A., Silva, D., Baptista, P., Henriques, J., Ferreira, C., et al. (2009). Development of a new chitosan hydrogel for wound dressing. Wound Repair Regener. 17, 817–824. doi: 10.1111/j.1524-475X.2009.00538.x
Romero-Sánchez, L. B., Marí-Beffa, M., Carrillo, P., Medina, M. Á., and Díaz-Cuenca, A. (2018). Copper-containing mesoporous bioactive glass promotes angiogenesis in an in vivo zebrafish model. Acta Biomaterialia 68, 272–285. doi: 10.1016/j.actbio.2017.12.032
Rostan, E. F., DeBuys, H. V., Madey, D. L., and Pinnell, S. R. (2002). Evidence supporting zinc as an important antioxidant for skin. Int. J. Dermatol. 41, 606–611. doi: 10.1046/j.1365-4362.2002.01567.x
Rowan, M. P., Cancio, L. C., Elster, E. A., Burmeister, D. M., Rose, L. F., Natesan, S., et al. (2015). Burn wound healing and treatment: review and advancements. Crit Care 19:243. doi: 10.1186/s13054-015-0961-2
Sawhney, C. (1989). Amniotic membrane as a biological dressing in the management of burns. Burns 15, 339–342. doi: 10.1016/0305-4179(89)90015-6
Sen, C. K., Khanna, S., Venojarvi, M., Trikha, P., Ellison, E., Hunt, T. K., et al. (2002). Copper-induced vascular endothelial growth factor expression and wound healing. Am. J. Physiol. Heart Circul. Physiol. 282, H1821–H1827. doi: 10.1152/ajpheart.01015.2001
Sevitt, S. (1979). A review of the complications of burns, their origin and importance for illness and death. J. Trauma. 19, 358–369. doi: 10.1097/00005373-197905000-00010
Sezer, A. D., Cevher, E., Hatipoglu, F., Ogurtan, Z., Baş, A., Akbuga, J., et al. (2008). Preparation of fucoidan-chitosan hydrogel and its application as burn healing accelerator on rabbits. Biol. Pharm. Bull. 31, 2326–2333. doi: 10.1248/bpb.31.2326
Sharma, B., Harish, D., Singh, V. P., and Bangar, S. (2006). Septicemia as a cause of death in burns: an autopsy study. Burns 32, 545–549. doi: 10.1016/j.burns.2006.02.008
Silvestry-Rodriguez, N., Sicairos-Ruelas, E. E., Gerba, C. P., and Bright, K. R. (2007). Silver as a disinfectant. Rev. Environ. Contam. Toxicol. 191, 23–45. doi: 10.1007/978-0-387-69163-3_2
Sinha, R., Agarwal, R., and Agarwal, M. (1997). Povidone iodine plus neosporin in superficial burns—a continuing study. Burns 23, 626–628. doi: 10.1016/S0305-4179(97)00069-7
Sirelkhatim, A., Mahmud, S., Seeni, A., Kaus, N. H. M., Ann, L., Bakhori, S. K., et al. (2015). Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett. 7, 219–242. doi: 10.1007/s40820-015-0040-x
Sommer, K., Sander, A. L., Albig, M., Weber, R., Henrich, D., Frank, J., et al. (2013). Delayed wound repair in sepsis is associated with reduced local pro-inflammatory cytokine expression. PLoS One 8:e73992. doi: 10.1371/journal.pone.0073992
Steinstraesser, L., Koehler, T., Jacobsen, F., Daigeler, A., Goertz, O., Langer, S., et al. (2008). Host defense peptides in wound healing. Mol. Med. 14, 528–537. doi: 10.2119/2008-00002.Steinstraesser
Thompson, M. G., Truong-Le, V., Alamneh, Y. A., Black, C., Anderl, J., Honnold, C. L., et al. (2015). Evaluation of gallium citrate formulations against a multidrug-resistant strain of Klebsiella pneumoniae in a murine wound model of infection. Antimicrob. Agents Chemother. 00882–15. doi: 10.1128/AAC.00882-15
Ueno, M., Lyons, B. L., Burzenski, L. M., Gott, B., Shaffer, D. J., Roopenian, D. C., et al. (2005). Accelerated wound healing of alkali-burned corneas in MRL mice is associated with a reduced inflammatory signature. Invest. Ophthalmol. Visual Sci. 46, 4097–4106. doi: 10.1167/iovs.05-0548
Varmette, E. A., Nowalk, J. R., Flick, L. M., and Hall, M. M. (2009). Abrogation of the inflammatory response in LPS-stimulated RAW 264.7 murine macrophages by Zn-and Cu-doped bioactive sol–gel glasses. J. Biomedical Mater. Res. Part A. 90, 317–325. doi: 10.1002/jbm.a.32098
Ventola, C. L. (2015). The antibiotic resistance crisis: part 1: causes and threats. Pharm. Therapeut. 40, 277–283.
Wajda, A., Goldmann, W. H., Detsch, R., Boccaccini, A. R., and Biswas, K. (2019). Influence of zinc ions on structure, bioactivity, biocompatibility and antibacterial potential of melt-derived and gel-derived glasses from CaO-SiO2 system. J. Non-Crystal. Solids 511, 86–99. doi: 10.1016/j.jnoncrysol.2018.12.040
Wang, T., Gu, Q., Zhao, J., Mei, J., Shao, M., Pan, Y., et al. (2015). Calcium alginate enhances wound healing by up-regulating the ratio of collagen types I/III in diabetic rats. Int. J. Clin. Exp. Pathol. 8:6636.
Wang, X., Chen, W., Liu, Q., Gao, K., Wang, G., Gao, L., et al. (2017). Function and mechanism of mesoporous bioactive glass adsorbed epidermal growth factor for accelerating bone tissue regeneration. Biomed. Mater. 12:025020. doi: 10.1088/1748-605X/aa65d8
Wang, X., Cheng, F., Liu, J. J.-, Smått, H., Gepperth, D., Lastusaari, M., et al. (2016). Biocomposites of copper-containing mesoporous bioactive glass and nanofibrillated cellulose: biocompatibility and angiogenic promotion in chronic wound healing application. Acta Biomaterialia 46, 286–298. doi: 10.1016/j.actbio.2016.09.021
Wang, Y., Beekman, J., Hew, J., Jackson, S., Issler-Fisher, A. C., Parungao, R., et al. (2018). Burn injury: challenges and advances in burn wound healing, infection, pain and scarring. Adv. Drug Deliv. Rev. 123, 3–17. doi: 10.1016/j.addr.2017.09.018
Whitacre, C., Apseloff, G., Cox, K., Matkovic, V., Jewell, S., and Gerber, N. (1992). Suppression of experimental autoimmune encephalomyelitis by gallium nitrate. J. Neuroimmunol. 39, 175–181. doi: 10.1016/0165-5728(92)90186-O
Wiegand, C., Abel, M., Ruth, P., Elsner, P., and Hipler, U. C. (2015). pH influence on antibacterial efficacy of common antiseptic substances. Skin Pharmacol. Physiol. 28, 147–158. doi: 10.1159/000367632
Wu, C., and Chang, J. (2014). Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug/growth factors. J. Control. Release 193, 282–295. doi: 10.1016/j.jconrel.2014.04.026
Wu, C., Zhou, Y., Xu, M., Han, P., Chen, L., Chang, J., et al. (2013). Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. Biomaterials 34, 422–433. doi: 10.1016/j.biomaterials.2012.09.066
Xynos, I. D., Edgar, A. J., Buttery, L. D., Hench, L. L., and Polak, J. M. (2000). Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem. Biophys. Res. Commun. 276, 461–465. doi: 10.1006/bbrc.2000.3503
Yu, H., Peng, J., Xu, Y., Chang, J., and Li, H. (2015). Bioglass activated skin tissue engineering constructs for wound healing. ACS Appl. Mater. Inter. 8, 703–715. doi: 10.1021/acsami.5b09853
Zelt, R. G., Daniel, R. K., Ballard, P. A., Brissette, Y., and Heroux, P. (1988). High-voltage electrical injury: chronic wound evolution. Plastic Reconst. Surg. 82, 1027–1041. doi: 10.1097/00006534-198812000-00014
Zhang, D., Leppäranta, O., Munukka, E., Ylänen, H., Viljanen, M. K., Eerola, E., et al. (2010). Antibacterial effects and dissolution behavior of six bioactive glasses. J. Biomed. Mater. Res. Part A. 93, 475–483. doi: 10.1002/jbm.a.32564
Keywords: bioactive glasses, burns, wound healing, ion release, angiogenesis, antibacterial activity
Citation: Kargozar S, Mozafari M, Hamzehlou S and Baino F (2019) Using Bioactive Glasses in the Management of Burns. Front. Bioeng. Biotechnol. 7:62. doi: 10.3389/fbioe.2019.00062
Received: 03 February 2019; Accepted: 07 March 2019;
Published: 28 March 2019.
Edited by:
Francesca Taraballi, Houston Methodist Research Institute, United StatesReviewed by:
Antonella Sola, University of Modena and Reggio Emilia, ItalyAhmed El-Fiqi, Dankook University, South Korea
Copyright © 2019 Kargozar, Mozafari, Hamzehlou and Baino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Saeid Kargozar, kargozarsaeid@gmail.com
Francesco Baino, francesco.baino@polito.it